Menopausal Hot Flashes Market: Innovations in Devices Attract Healthcare Companies

Treatment Options Targeting Brain’s Thermostat Lead to Innovations in Non-hormonal Drugs

High prevalence of fluctuating estrogen levels and depleting musculoskeletal health among women are some of the key drivers contributing to the robust growth of the menopausal hot flashes market. Hence, healthcare companies are increasing their clinical trials in non-hormonal products to meet various cases. Recently, in January 2020, the U.K.-based clinical-stage biotech company KaNDy Therapeutics, announced positive data of their Phase 2b “SWITCH-1” clinical trial of their novel lead non-hormonal drug candidate, NT-814, for the treatment of menopause. Though the hormonal treatment type segment is expected to lead the menopausal hot flashes market, non-hormonal treatment type segment is anticipated for exponential growth during the forecast period.

Companies in the market for menopausal hot flashes are increasing R&D in treatment options that target the brain’s thermostat to reduce incidence of hot flashes in women. Such innovations are creating value-grab opportunities for companies in the market menopausal hot flashes market, whilst improving the quality of life of postmenopausal women.

Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2856

• Menopause is defined as the permanent cessation of menses that may occur in as early as the thirties or as late as the sixties. The treatment and management of menopausal women has been a matter of great apprehension in the last few decades, both in terms of epidemiology and medical scientific research.
• The most common menopausal symptoms, including vasomotor symptoms (menopausal hot flashes), insomnia, vaginal atrophy, altered cognitive function, dementia, depression, and loss of muscle mass, can affect up to 80% of women during menopause and may be severe in up to 20% of these women
• Menopausal hot flashes symptoms treatment drugs are used to reduce hot flashes, which is a form of temperature dysfunction that occurs due to changes in gonadal hormones. Menopausal hot flashes symptom treatments are classified into hormonal treatment, non-hormonal treatment, and alternative treatment (including herbal products).
• Hormonal treatment products are available in different dosage forms such as pill, patch, and gel. The use of hormone replacement therapy (HRT) alleviates menopausal hot flashes symptoms and leads to a major improvement in quality of life for women with menopausal hot flashes symptoms.
• Growing population of elderly women worldwide coupled with rise in menopausal hot flashes symptoms is a major factor responsible for the growth of global menopausal hot flashes market
• Increase in awareness about women’s health due to different public as well as private organizations initiatives is also fueling the growth of global menopausal hot flashes market
• Moreover, development of advanced products with alternative mode of administration and changes in lifestyle associated with early menopause are some of the major factors attributed for the growth of global menopausal hot flashes market

Request for Analysis of COVID19 Impact on Menopausal Hot Flashes Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=2856

• Based on treatment type, the global menopausal hot flashes market has been divided into hormonal treatment, non-hormonal treatment, and alternative treatment
• Hormonal treatment is further classified into estrogen, progesterone, and estrogen - progesterone combination
• The non-hormonal segment is sub-segmented into antidepressant, gabapentin, pregabalin, and clonidine. Antidepressant is further divided into Paroxetine, Fluoxetine, Vanlafaxine, Desvanlafaxine, and others.
• The alternative segment is further sub-divided into black cohosh, vitamin E, herbal medicines, and others
• Based on distribution channel, the global menopausal hot flashes market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies
• Each of the segments has been analyzed in detail for global menopausal hot flashes market trends, recent trends, and developments, drivers, restraints, opportunities, and useful insights
• The global menopausal hot flashes report provides current and future revenues (US$ Mn) for each these segments for the period from 2017 to 2027, considering 2018 as the base year. The compound annual growth rate (% CAGR) has been provided for each segment and market from 2019 to 2027 along with menopausal hot flashes market size estimations.

Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=2856

• In terms of region, the global menopausal hot flashes market has been divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been further divided into major countries and sub-regions.
• The current and future market sizes for menopausal hot flashes market in terms of revenue (US$ Mn) of these regional markets and their major countries have been provided in the report for the period from 2017 to 2027, with their CAGRs for the period from 2019 to 2027
• The study also offers a list of recommendations, highlights, and useful insights of the global menopausal hot flashes market which will help new companies willing to enter the market and existing companies to increase market shares, and help in the decision-making process

Buy Menopausal Hot Flashes Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=2856&ltype=S

• The global menopausal hot flashes report concludes with the company profiles section that includes key information about the major players in the market
• Key players analyzed in this global menopausal hot flashes market include -
  • Pfizer Inc.
  • Novartis AG
  • Novo Nordisk A/S
  • Allergan plc
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Hisamitsu Pharmaceutical Co., Inc.
  • Merck & Co., Inc.
  • GlaxoSmithKline plc
  • TherapeuticsMD, Inc
• Each of these players has been profiled in the menopausal hot flashes market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/